3rd Circuit Affirms Dismissal Of Drug Rebate False Claims Act Suit
PHILADELPHIA — The Third Circuit U.S. Court of Appeals on Aug. 16 affirmed dismissal of a whistleblower lawsuit accusing eight drug manufacturers of miscalculating their drug prices and shorting rebates owed...To view the full article, register now.
Already a subscriber? Click here to view full article